Concepedia

Publication | Open Access

Protocol of DREAM3R: DuRvalumab with chEmotherapy as first-line treAtment in advanced pleural Mesothelioma—a phase 3 randomised trial

28

Citations

17

References

2022

Year

Abstract

ClinicalTrials.gov Identifier: NCT04334759 ACTRN 12620001199909.

References

YearCitations

Page 1